[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

IMARC Group: Market Research Reports

The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.

IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.

The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.

Publications found: 11,648
Sort by:

Pulmonary Sarcoidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major pulmonary sarcoidosis markets reached a value of US$ 17.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 53.3 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 128 pages

Pyoderma Gangrenosum Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major pyoderma gangrenosum markets reached a value of US$ 126.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 185.1 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 131 pages

Pyruvate Kinase Deficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major pyruvate kinase deficiency markets are expected to exhibit a CAGR of 3.99% during 2024-2034. The pyruvate kinase deficiency market has been comprehensively analyzed in IMARC's new report t...

May 2024 138 pages

Raynaud's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major Raynaud's disease markets are expected to exhibit a CAGR of 7.68% during 2024-2034. The Raynaud's disease market has been comprehensively analyzed in IMARC's new report titled 'Raynaud's D...

May 2024 131 pages

Recurrent Glioblastoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major recurrent glioblastoma markets are expected to exhibit a CAGR of 5.85% during 2024-2034. The recurrent glioblastoma market has been comprehensively analyzed in IMARC's new report titled 'R...

May 2024 130 pages

Recurrent Head and Neck Squamous Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major recurrent head and neck squamous cell carcinoma markets reached a value of US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.5 Billion by 2034, exhibitin...

May 2024 128 pages

Recurrent Malignant Glioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major recurrent malignant glioma markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.2 Billion by 2034, exhibiting a growth rate (CAGR...

May 2024 130 pages

Recurrent Pericarditis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major recurrent pericarditis markets are expected to exhibit a CAGR of 4.08% during 2024-2034. The recurrent pericarditis market has been comprehensively analyzed in IMARC's new report titled 'R...

May 2024 134 pages

Relapsed Refractory Multiple Myeloma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major relapsed refractory multiple myeloma markets reached a value of US$ 21.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 34.4 Billion by 2034, exhibiting a growt...

May 2024 128 pages

Renal Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major renal cell carcinoma markets reached a value of US$ 4.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.3 Billion by 2034, exhibiting a growth rate (CAGR) of 4...

May 2024 134 pages

Renal Insufficiency Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major renal insufficiency markets reached a value of US$ 9.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 22.7 Billion by 2034, exhibiting a growth rate (CAGR) of 8...

May 2024 137 pages

Respiratory Distress Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major respiratory distress syndrome markets are expected to exhibit a CAGR of 4.56% during 2024-2034. The respiratory distress syndrome market has been comprehensively analyzed in IMARC's new re...

May 2024 133 pages

Respiratory Syncytial Virus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major respiratory syncytial virus markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.8 Billion by 2034, exhibiting a growth rate (CAG...

May 2024 134 pages

Restless Legs Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major restless legs syndrome markets are expected to exhibit a CAGR of 2.49% during 2024-2034. The restless legs syndrome market has been comprehensively analyzed in IMARC's new report titled 'R...

May 2024 130 pages

Retinal Edema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major retinal edema markets reached a value of US$ 5.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 13.5 Billion by 2034, exhibiting a growth rate (CAGR) of 7.84% d...

May 2024 135 pages

Retinitis Pigmentosa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major retinitis pigmentosa markets reached a value of US$ 9.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 17.1 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 133 pages

Retinopathy of Prematurity Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major retinopathy of prematurity markets are expected to exhibit a CAGR of 5.1% during 2024-2034. The retinopathy of prematurity market has been comprehensively analyzed in IMARC's new report ti...

May 2024 139 pages

Rett Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major Rett syndrome markets reached a value of US$ 182.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 419.4 Million by 2034, exhibiting a growth rate (CAGR) of 7.85...

May 2024 131 pages

Rheumatic Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major rheumatic diseases markets reached a value of US$ 24.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 29.0 Billion by 2034, exhibiting a growth rate (CAGR) of 1...

May 2024 128 pages

Rheumatoid Arthritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major rheumatoid arthritis markets reached a value of US$ 27.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 33.8 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 133 pages

Rhinosinusitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major rhinosinusitis markets reached a value of US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4.64% d...

May 2024 129 pages

Richter's Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The Richter's syndrome market size in top seven countries reached US$ 448.8 Million in 2023. Looking forward, IMARC Group expects the market in top seven countries to reach US$ 713.2 Million by 2034,...

May 2024 131 pages

Ringworm Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major ringworm markets are expected to exhibit a CAGR of 3.49% during 2024-2034. The ringworm market has been comprehensively analyzed in IMARC's new report titled 'Ringworm Market: Epidemiology...

May 2024 133 pages

Rosai-Dorfman Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major Rosai-Dorfman disease markets reached a value of US$ 318.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 568.9 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 131 pages

Rotavirus Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major rotavirus markets are expected to exhibit a CAGR of 8.62% during 2024-2034. The rotavirus market has been comprehensively analyzed in IMARC's new report titled 'Rotavirus Market: Epidemiol...

May 2024 131 pages

Rubella Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major rubella markets are expected to exhibit a CAGR of 4.31% during 2024-2034. The rubella market has been comprehensively analyzed in IMARC's new report titled 'Rubella Market: Epidemiology, I...

May 2024 139 pages

Sandhoff Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major Sandhoff disease markets are expected to exhibit a CAGR of 3.07% during 2024-2034. The Sandhoff disease market has been comprehensively analyzed in IMARC's new report titled 'Sandhoff Dise...

May 2024 135 pages

Sanfilippo Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major sanfilippo syndrome markets reached a value of US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.5 Billion by 2034, exhibiting a growth rate (CAGR) of 3....

May 2024 135 pages

Sarcoidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major sarcoidosis markets reached a value of US$ 194.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 289.7 Million by 2034, exhibiting a growth rate (CAGR) of 3.68%...

May 2024 137 pages

Sarcopenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major sarcopenia markets reached a value of US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.3 Billion by 2034, exhibiting a growth rate (CAGR) of 4.1% during...

May 2024 128 pages

Scedosporium Infection Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major Scedosporium infection markets are expected to exhibit a CAGR of 5.8% during 2024-2034. The Scedosporium infection market has been comprehensively analyzed in IMARC's new report titled 'Sc...

May 2024 140 pages

Schistosomiasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major schistosomiasis markets reached a value of US$ 52.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 71.4 Million by 2034, exhibiting a growth rate (CAGR) of 2.92...

May 2024 131 pages

Schizoaffective Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major schizoaffective disorder markets are expected to exhibit a CAGR of 2.21% during 2024-2034. The schizoaffective disorder market has been comprehensively analyzed in IMARC's new report title...

May 2024 137 pages

Schizophrenia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major schizophrenia markets reached a value of US$ 9,480.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 15,236.9 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 128 pages

Sciatica Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major sciatica markets reached a value of US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.2 Billion by 2034, exhibiting a growth rate (CAGR) of 2.62% during...

May 2024 128 pages

Scleroderma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major scleroderma markets are expected to exhibit a CAGR of 4.38% during 2024-2034. The scleroderma market has been comprehensively analyzed in IMARC's new report titled 'Scleroderma Market: Epi...

May 2024 136 pages

Scoliosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major scoliosis markets reached a value of US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3% during 20...

May 2024 129 pages

Seasonal Allergic Rhinitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The seasonal allergic rhinitis market reached a value of US$ 10.5 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$...

May 2024 140 pages

Seasonal Influenza Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major seasonal influenza markets reached a value of US$ 8.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 41.6 Billion by 2034, exhibiting a growth rate (CAGR) of 15...

May 2024 133 pages

Seborrhea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major seborrhea markets are expected to exhibit a CAGR of 7.55% during 2024-2034. The seborrhea market has been comprehensively analyzed in IMARC's new report titled 'Seborrhea Market: Epidemiol...

May 2024 134 pages

Seizures Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major seizures markets reached a value of US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.9 Billion by 2034, exhibiting a growth rate (CAGR) of 4.17% during...

May 2024 132 pages

Sepsis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major sepsis markets reached a value of US$ 438.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 907.3 Million by 2034, exhibiting a growth rate (CAGR) of 6.84% durin...

May 2024 131 pages

Septic Shock Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major septic shock markets are expected to exhibit a CAGR of 6.53% during 2024-2034. The septic shock market has been comprehensively analyzed in IMARC's new report titled 'Septic Shock Market:...

May 2024 128 pages

Severe Acute Respiratory Syndrome Coronavirus Infection Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major severe acute respiratory syndrome coronavirus infection markets reached a value of US$ 21.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 68.5 Billion by 2034,...

May 2024 129 pages

Sexually Transmitted Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major sexually transmitted disease markets reached a value of US$ 40.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 95.0 Billion by 2034, exhibiting a growth rate (...

May 2024 128 pages

Sezary Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major Sezary syndrome markets are expected to exhibit a CAGR of 3.99% during 2024-2034. The Sezary syndrome market has been comprehensively analyzed in IMARC's new report titled 'Sezary Syndrome...

May 2024 140 pages

Short Bowel Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major short bowel syndrome markets are expected to exhibit a CAGR of 20.52% during 2024-2034. The short bowel syndrome market has been comprehensively analyzed in IMARC's new report titled 'Shor...

May 2024 128 pages

Sialidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major sialidosis markets are expected to exhibit a CAGR of 6.9% during 2024-2034. The sialidosis market has been comprehensively analyzed in IMARC's new report titled 'Sialidosis Market: Epidemi...

May 2024 134 pages

Sick Sinus Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major sick sinus syndrome markets reached a value of US$ 4.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 7.9 Billion by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 133 pages

Sjogren's Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

 US$ 6,499.00

The 7 major Sjogren's syndrome markets reached a value of US$ 168.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 226.0 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 135 pages

Filters

Clear all

Search

Categories

18
13
12
10
9
8
8
7
7
6
6
5
4
4
3
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
75
56
45
45
44
41
41
38
38
31
30
29
28
27
26
26
24
24
23
23
23
22
22
21
21
21
21
21
20
20
19
19
19
19
18
18
17
17
16
16
15
15
15
14
14
14
14
14
13
13
13
13
13
12
12
12
12
12
12
12
11
11
11
11
11
11
11
11
10
10
10
10
10
10
10
10
10
9
9
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
80
22
20
17
13
12
10
10
10
10
10
10
9
9
9
8
8
7
6
6
6
6
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
22
21
18
14
14
14
13
13
13
13
12
12
10
8
8
7
7
7
7
6
6
6
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
41
31
29
25
22
20
8
7
7
5
4
4
4
3
3
2
2
1
1
1
1
49
34
33
16
7
5
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
23
13
13
9
7
7
7
6
4
3
3
2
1
1
1
6
4
4
3
2
1
32
9
25
1
1,751
55
26
30
213
64
26
25
15
13
1
3
150
141
158
9
252
191
27
21
7
40
6
2
2
21
401
162
15
232
19
261
225
18
7
45
25
17
16
12

Publishers

11,648

Regions

1
1
123
22
14
11
7
5
4
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
8
3
2
1
6
3
3
2
1
1
13
11,187
5
9
19
11
2
141
13

Price

—

Date

—

Pages

—

Offers